(NYSE:SOC), NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces it has filed a class action lawsuit on behalf of purchasers of the securities of Sable Offshore Corp. (NYSE: SOC): (1) between May 19, 2025 and June 3, 2025, both dates inclusive (the “Class Period”); and/or (2) pursuant […]
Shareholders who lost money on Sable Offshore Corp. (NYSE: SOC) Should Contact Wolf Haldenstein Immediately as Lead Plaintiff Deadline is September 26nd GlobeNewswire July 31, 2025 NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP announces it has filed a class action lawsuit on behalf of purchasers of the
NEW YORK, NY / ACCESS Newswire / July 31, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=159145&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
The treatment-resistant hypertension (TRH) market is expected to grow in the coming years due to the rising prevalence of uncontrolled hypertension and associated cardiovascular risks. Increasing awareness, improved diagnostic practices, and innovations in combination therapies, as well as device-based interventions, are driving market expansion. DelveInsight's Treatment Resistant Hypertension Market Insights report includes a comprehensive understanding
NEW YORK, NY / ACCESS Newswire / July 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of BellRing Brands, Inc. ("BellRing Brands, Inc.") (NYSE:BRBR) concerning possible violations of federal securities laws. On May 6, 2025, BellRing Brands during its second quarter of 2025 earnings call revealed that certain customers
NEW YORK, NY / ACCESS Newswire / July 31, 2025 / If you suffered a loss on your Centene Corporation (NYSE:CNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=159144&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
Study Will Compare Four Amnion-Based Therapies Plus Standard of Care to Standard of Care Alone in Chronic Wound Management BioLab Holdings, Inc., a Phoenix-based medical manufacturer specializing in regenerative wound care, has initiated its most comprehensive clinical trial to date. The multicenter, prospective, randomized controlled study will evaluate the efficacy of four human placental membrane
(TSX-V:ATI), TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that it has filed a management information circular (the “Circular”) and related meeting materials (together with the Circular, the “Meeting Materials”) in connection with a special meeting (the “Meeting”) of shareholders of the Company (the “Shareholders”)
Altai Announces Filing of Meeting Materials for Special Meeting of Shareholders GlobeNewswire July 31, 2025 TORONTO, July 31, 2025 (GLOBE NEWSWIRE) — Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that it has filed a management information circular (the “Circular”) and related meeting materials (together with the Circular, the “Meeting Materials”) in
(TSX:ERO),(NYSE:ERO), VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce its operating and financial results for the three and six months ended June 30, 2025. Management will host a conference call tomorrow, Friday, August 1, 2025, at 11:30 a.m. Eastern